标题
Ceftobiprole: drug evaluation and place in therapy
作者
关键词
-
出版物
Expert Review of Anti-Infective Therapy
Volume 17, Issue 9, Pages 689-698
出版商
Informa UK Limited
发表日期
2019-09-25
DOI
10.1080/14787210.2019.1667229
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials
- (2019) Thomas W. L. Scheeren et al. BMC INFECTIOUS DISEASES
- In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017
- (2019) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)
- (2018) M.A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Activity of ceftobiprole against Staphylococcus spec. isolates derived from foreign body associated infections
- (2018) Gunnar T.R. Hischebeth et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections
- (2018) Christophe Isnard et al. Journal of Global Antimicrobial Resistance
- Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria
- (2018) Matteo Bassetti et al. Current Opinion in Critical Care
- Bactericidal activity of Ceftobiprole combined with different antibiotics against selected gram-positive isolates
- (2018) F. Campanile et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient
- (2018) Pier Giorgio Cojutti et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Ceftobiprole medocaril for the treatment of community-acquired pneumonia
- (2018) Vicenç Falcó et al. EXPERT OPINION ON PHARMACOTHERAPY
- Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014–2015
- (2018) Anne Santerre Henriksen et al. Infection and Drug Resistance
- Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen
- (2017) A.M. Bal et al. Journal of Global Antimicrobial Resistance
- Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations
- (2016) Antonio Torres et al. CLINICAL PHARMACOKINETICS
- Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy
- (2016) Chiara Oltolini et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftobiprole: First Reported Experience in Osteomyelitis
- (2016) A MacDonald et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Exposure to Ceftobiprole Is Associated with Microbiological Eradication and Clinical Cure in Patients with Nosocomial Pneumonia
- (2014) A. E. Muller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftobiprole Activity against over 60,000 Clinical Bacterial Pathogens Isolated in Europe, Turkey, and Israel from 2005 to 2010
- (2014) David J. Farrell et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
- (2014) S. S. Awad et al. CLINICAL INFECTIOUS DISEASES
- Ceftobiprole Medocaril: A Review of Its Use in Patients with Hospital- or Community-Acquired Pneumonia
- (2014) Yahiya Y. Syed DRUGS
- Ceftobiprole and ampicillin increase daptomycin susceptibility of daptomycin-susceptible and -resistant VRE
- (2014) B. J. Werth et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
- (2014) K. E. Barber et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Monte Carlo Simulations Based on Phase 1 Studies Predict Target Attainment of Ceftobiprole in Nosocomial Pneumonia Patients: a Validation Study
- (2013) Anouk E. Muller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model
- (2013) Y. Barnea et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays
- (2013) Darren Abbanat et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Ceftobiprole EfficacyIn Vitroagainst Panton-Valentine Leukocidin Production andIn Vivoagainst Community-Associated Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rabbits
- (2012) Azzam Saleh-Mghir et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives
- (2012) Shrenik Mehta et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A randomised, double-blind trial comparing ceftobiprole medocaril with ceftriaxone with or without linezolid for the treatment of patients with community-acquired pneumonia requiring hospitalisation
- (2012) Susan C. Nicholson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Structural Insights into the Anti-methicillin-resistantStaphylococcus aureus(MRSA) Activity of Ceftobiprole
- (2012) Andrew L. Lovering et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effect of Ceftobiprole Treatment on Growth of and Toxin Production by Clostridium difficile in Cecal Contents of Mice
- (2011) Michelle M. Nerandzic et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VivoSynergism of Ceftobiprole and Vancomycin against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus
- (2011) J. M. Entenza et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Use of Antistaphylococcal -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding
- (2011) A. Dhand et al. CLINICAL INFECTIOUS DISEASES
- In vitro activity of ceftobiprole against frequently encountered aerobic and facultative Gram-positive and Gram-negative bacterial pathogens: results of the CANWARD 2007–2009 study
- (2011) Andrew Walkty et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time–kill methodology
- (2011) Michael Kresken et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Effect of ceftobiprole on the normal human intestinal microflora
- (2010) Tobias Bäckström et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Comparative activity of ceftobiprole against Gram-positive and Gram-negative isolates from Europe and the Middle East: the CLASS study
- (2010) G. M. Rossolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identifying Exposure Targets for Treatment of Staphylococcal Pneumonia with Ceftobiprole
- (2009) K. A. Rodvold et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined by In Vivo Microdialysis
- (2009) A. Barbour et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ceftobiprole Is Superior to Vancomycin, Daptomycin, and Linezolid for Treatment of Experimental Endocarditis in Rabbits Caused by Methicillin-Resistant Staphylococcus aureus
- (2009) P. Tattevin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Pharmacokinetics and Pharmacodynamics of Ceftobiprole, an Anti-MRSA Cephalosporin with Broad-Spectrum Activity
- (2009) Bindu Murthy et al. CLINICAL PHARMACOKINETICS
- Pharmacodynamic Characterization of Ceftobiprole in Experimental Pneumonia Caused by Phenotypically Diverse Staphylococcus aureus Strains
- (2008) S. Laohavaleeson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vivo Pharmacodynamics of Ceftobiprole against Multiple Bacterial Pathogens in Murine Thigh and Lung Infection Models
- (2008) W. A. Craig et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
- (2008) G. J. Noel et al. CLINICAL INFECTIOUS DISEASES
- In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin
- (2008) C. M. Pillar et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now